13A-1110210
PCT、TW pending
Spinal muscular atrophy (SMA) is a leading genetic cause of infant death characterized by the progressive death of motor neurons (MNs). SMA is caused by loss of Survival of Motor Neuron (SMN) protein essential for MN survival. MicroRNAs (miRNAs) are small RNAs that regulate post-transcriptional gene expression, including MNs. Emerging evidence suggests a crucial role of miRNA in SMA pathogenesis. We identified the mechanism underlying altered level of MiR-34 in human iPSC-derived MNs and mice model of SMA. Our invention verifies a specific SMA-miRNAs signature, and the potential of MiR-34 works as an SMA biomarker. Moreover, a significant correlation between MiR-34 in cerebrospinal fluids and motor function scales of SMA patients after antisense oligonucleotides treatment suggests its utilization in predicting SMA treatment response.
- Advanced detection methods provide greater sensitivity and precision of circulating miRNAs to work as disease biomarkers.
- Changes in miRNA (MiR-34) level can be detected in accessible human biofluids with relative stability - such as CSF, serum/plasma, saliva, and urine.
- MiR-34 can be simultaneously detected level changes in different tissues to monitor therapeutic response in SMA patients.
- MiR34 can be applied as follows:
- Prognostic biomarker to provide information on disease evolution and natural course of SMA patients.
- Predictive biomarker to evaluate treatment response of novel therapies in SMA patients
- Pharmacodynamic biomarker to monitor therapeutic efficacy and surrogate endpoint in drug development and clinical trials for SMA
- Working as a potential therapeutic target as Enhancement of MiR-34 expression may rescue SMA severity
Jun-An Chen, Yuh-Jyh Jong
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

MiR34 Contributes to Pivotal Multifaceted Morphological and Functional Abnormalities in Spinal Muscular Atrophy